Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01209533 · ClinicalTrials.gov registry record · Early Phase 1
Inhaled Iloprost in Mild Asthma
A Early Phase 1 study, sponsored by Vanderbilt University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 24
- Enrollment target
NCT01209533 is a Early Phase 1 study that has completed, run by Vanderbilt University. The registered enrollment target is 24 participants.
The verdict
NCT01209533, a Early Phase 1 study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of the study is to determine if inhaled iloprost given four times daily can improve symptoms and lung function in adults with mild asthma.
Interventions
- DRUG Iloprost
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2010-09 |
| Est. Completion | 2011-07 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01209533
The ClinicalTrials.gov registry entry for NCT01209533 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Iloprost is the first listed.
NCT01209533 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01209533 about?
NCT01209533 is a clinical study titled "Inhaled Iloprost in Mild Asthma". The purpose of the study is to determine if inhaled iloprost given four times daily can improve symptoms and lung function in adults with mild asthma.
What is the current status of trial NCT01209533?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 24 participants. The study started on 2010-09. Estimated completion is 2011-07.
What interventions are being tested in trial NCT01209533?
The interventions under investigation include: Iloprost (DRUG).
Who is sponsoring clinical trial NCT01209533?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.